Cargando…
First person – Venkatram Yellapragada
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Venkatram Yellapragada is first author on ‘ FGF8–FGFR1 signaling regulates human GnRH neuro...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403747/ http://dx.doi.org/10.1242/dmm.049763 |
_version_ | 1784773448415838208 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Venkatram Yellapragada is first author on ‘ FGF8–FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner’, published in DMM. He is a doctoral candidate in the lab of Taneli Raivio at the University of Helsinki, and investigates the modeling of human diseases in vitro in order to identify their underlying pathophysiology. |
format | Online Article Text |
id | pubmed-9403747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-94037472022-08-25 First person – Venkatram Yellapragada Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Venkatram Yellapragada is first author on ‘ FGF8–FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner’, published in DMM. He is a doctoral candidate in the lab of Taneli Raivio at the University of Helsinki, and investigates the modeling of human diseases in vitro in order to identify their underlying pathophysiology. The Company of Biologists Ltd 2022-08-16 /pmc/articles/PMC9403747/ http://dx.doi.org/10.1242/dmm.049763 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Venkatram Yellapragada |
title | First person – Venkatram Yellapragada |
title_full | First person – Venkatram Yellapragada |
title_fullStr | First person – Venkatram Yellapragada |
title_full_unstemmed | First person – Venkatram Yellapragada |
title_short | First person – Venkatram Yellapragada |
title_sort | first person – venkatram yellapragada |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403747/ http://dx.doi.org/10.1242/dmm.049763 |